Literature DB >> 11992589

Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?

Leslie Ann Mitchell1.   

Abstract

This review focuses on the role that human parvovirus B19 nonstructural (NS1) protein as a transactivator of the proinflammatory cytokine, interleukin-6 (IL-6), might play in triggering the multiparametric inflammatory outcomes of B19 infection. Parvovirus B19 is a ubiquitous virus, and it is often expressed during conditions of immunodepression including that induced by long-term chemotherapy, viral infection (HIV, HTLV-1), or genetic immunodeficiency disorders. Through NS1 expression, B19 may contribute to the immune dysregulation associated with these disorders, or serve as a cofactor in enhancing retroviral replication. Hence, NS1 transactivation of proinflammatory cytokine promoters such as IL-6 may be pivotal in triggering the various inflammatory and autoimmune disorders that have been linked to parvovirus B19 infections. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992589     DOI: 10.1002/jmv.2217

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Parvovirus B19 Infection in Human Bone Marrow Mesenchymal Stem Cells Affects Gene Expression of IL-6 and TNF-α and also Affects Hematopoietic Stem Cells Differentiation.

Authors:  Mahin Behzadi Fard; Saeid Kaviani; Amir Atashi
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-02       Impact factor: 0.900

2.  Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations.

Authors:  Y Mehraein; M Wagner; K Remberger; L Füzesi; P Middel; S Kaptur; K Schmitt; E Meese
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

3.  Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.

Authors:  Adrian Lupescu; C-Thomas Bock; Philipp A Lang; Susanne Aberle; Heike Kaiser; Reinhard Kandolf; Florian Lang
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 4.  Advances in human B19 erythrovirus biology.

Authors:  Annabelle Servant-Delmas; Jean-Jacques Lefrère; Frédéric Morinet; Sylvie Pillet
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

5.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

6.  Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

Authors:  Thomas A O'Bryan; Stanley J Naides
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

7.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

8.  Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.

Authors:  T-C Hsu; B-S Tzang; C-N Huang; Y-J Lee; G-Y Liu; M-C Chen; G J Tsay
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

9.  Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

Authors:  Anja Duechting; Carsten Tschöpe; Heike Kaiser; Tobias Lamkemeyer; Nobuyuki Tanaka; Susanne Aberle; Florian Lang; Joseph Torresi; Reinhard Kandolf; C-Thomas Bock
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

10.  Cytokine profiles in adult mink infected with Aleutian mink disease parvovirus.

Authors:  P V Jensen; Y Castelruiz; B Aasted
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.